Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Omeprazole, Ibuprofen Among OTCs Listed On Medicare Rx Price Website

This article was originally published in The Tan Sheet

Executive Summary

The new Medicare prescription drug price comparison 1website includes information on a handful of OTC-strength products including omeprazole 20 mg (Prilosec OTC)

You may also be interested in...



Insurers back Prilosec OTC

Humana joins list of insurers offering coupons for switch drug, firm announces Sept. 25. Members that "take prescription medication for chronic heartburn" will be mailed coupon for free 14-count package. Separately, North Carolina Blue Cross/Blue Shield sending more than 40,000 coupons provided by P&G for $10 off retail to "frequent sufferers of intermittent heartburn." Insurer drops Rx Prilosec, omeprazole coverage, shifts follow-on prescription PPI Nexium to higher co-pay tier. Moves follow similar action by WellPoint (1"The Tan Sheet" Sept. 15, 2003, p.3)...

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096776

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel